Skip navigation

Calls to Action

Massachusetts General Hospital

Research Supported by the Autism Speaks Autism Treatment Network Presented at the Society for Developmental & Behavioral Pediatrics Annual Meeting

Research supported by the Autism Speaks Autism Treatment Network demonstrating that symptoms of attention deficit and hyperactivity wor

September 18, 2011
NEW YORK, N.Y. (September 18, 2011) – Research supported by the Autism Speaks Autism Treatment Network (ATN), demonstrating that symptoms of attention deficit and hyperactivity worsen quality of life for individuals with autism spectrum disorders (ASD), was presented today at the Society for Developmental & Behavioral Pediatrics Annual Meeting in San Antonio, Texas.
Search for a candidate gene in autism

Julia Bailey, Ph.D., University of California, Los Angeles (Young Investigator)

Conditional neurotrophin knock-out mice as a model for the developmental neuropathology of autism

Schahram Akbarian, Ph.D., Massachusetts General Hospital (Young Investigator)

Molecular Studies in Autism

Huda Zoghbi, M.D., Baylor College of Medicine (Genius Award)
The funds received through the Cure Autism Now Genius Award will allow us to explore new approaches to identify some of the molecular genetic pathways involved in autism. Our strategy will focus on the following hypothesis: Genes that are key in mediating prominent phenotypes seen in autistic patients are likely to be mutated, at least, in a subset of autism patients. A two-pronged approach will be taken to hone in on the most promising candidate pathways.